DOI QR코드

DOI QR Code

고체상추출과 GC/MS를 이용한 소변 중 암페타민계 마약성분 동시분석법

Simultaneous determination of amphetamine-like drugs in human urine by SPE and GC/MS

  • Cheong, Jae Chul (Drug Analysis Laboratory, Forensic Science Division, Supreme Prosecutors' Office) ;
  • Kim, Jin Young (Drug Analysis Laboratory, Forensic Science Division, Supreme Prosecutors' Office) ;
  • In, Moon Kyo (Drug Analysis Laboratory, Forensic Science Division, Supreme Prosecutors' Office) ;
  • Cheong, Won Jo (Department of Chemistry, Inha University)
  • 투고 : 2007.08.28
  • 심사 : 2007.11.19
  • 발행 : 2008.02.25

초록

소변 중 암페타민계 5성분(amphetamine; AP, methamphetamine; MA, 3,4-methylenedioxyamphetamine; MDA, 3,4-methylenedioxymethamphetamine; MDMA, 3,4-methylenedioxyethylamphetamine; MDEA)의 동시분석을 위하여 기존의 액체상추출(liquid-liquid extraction; LLE) 방법과는 달리 감정과정의 자동화가 가능한 고체상추출(solid-phase extraction, SPE) 방법을 도입하였다. 시험관에 소변 3 mL와 0.1 M 인산완충액 1 mL (pH 7.0)를 넣고, 자동추출장치를 이용하여 추출하고, 증발 건고하여 유도체화 한 다음 GC/MS로 분석하였다. 그 결과 검정곡선의 직선성 상관계수 ($r^2$)는 AP와 MDA [농도범위 34.0 (AP), 28.0 (MDA)~1000.0 ng/mL] 및 MA, MDMA, MDEA (농도범위 50.0~2000.0 ng/mL)에서 0.994 이상으로 나타났다. 그리고 각 성분들의 검출한계 (LOD)는 4.0~10.0 ng/mL 범위였고, 정량한계 (LOQ)는 12.0~34.0 ng/mL 범위였다. 상대 회수율은 5성분 모두 93.5~107.7%로 측정되었다. 정밀도 (precision)와 정확도 (accuracy)는 각각 1.9~14.8%와 -8.7~14.8 % 범위 값을 나타냈다. 본 실험방법을 실제 남용자 소변에 적용한 결과 메스암페타민 또는 엑스터시 투약자를 신속하고 정확하게 동시에 확인할 수 있었다.

Although liquid-liquid extraction (LLE) method has been used routinely for the analysis of amphetamine-like drugs (amphetamine; AP, methamphetamine; MA, 3,4-methylenedioxyamphetamine; MDA, 3,4-methylenedioxymethamphetamine; MDMA, 3,4-methylenedioxyethylamphetamine; MDEA), a solid-phase extraction (SPE) method, which can be automated, was applied for the simultaneous determination by GC/MS in human urine. Urine samples (3 mL) and 0.1 M phosphate buffer (1 mL, pH 7.0) were extracted by an automated SPE system. The eluent was evaporated, derivatized with trifluoroacetic anhydride (TFAA), and analyzed by GC/MS. The calibration curves was linear with correlation coefficient ($r^2$) above 0.994 in the ranges of 34.0 (AP), 28.0 (MDA)~1000.0 ng/mL for AP, MDA, and 50.0~2000.0 ng/mL for MA, MDMA, and MDEA. The limits of detection ranged from 4.0 to 10.0 ng/mL, and the limits of quantitation ranged from 12.0 to 34.0 ng/mL. The relative recoveries were 93.5~107.7 %. The precisions and accuracies were 1.9~14.8 % and -8.7~14.8 %, respectively. The present method was successfully applied to identify the MA or Ecstasy (MDMA) abusers in exact as well as rapid.

키워드

참고문헌

  1. G. W. Kunsman, B. Levine, J. J. Kuhlman, R. L. Jones, R. O. Hughes, C. I. Fujiyama, and M. L. Smith, J. Anal. Toxicol., 20(7), 517-521(1996) https://doi.org/10.1093/jat/20.7.517
  2. J. K. Fallon, A. T. Kicman, J. A. Henry, P. J. Milligan, D. A. Cowan, and A. J. Hutt, Clin. Chem., 45(7), 1058- 1069(1999)
  3. 김진영, 서승일, 고범준, 이재일, 정재철, 서용준, 인 문교, 약학회지, 47(3), 142-147(2003)
  4. G. W. Kunsman, J. E. Manno, K. R. Cockerham, and B. R. Manno, J. Anal. Toxicol., 14(3), 149-153(1990) https://doi.org/10.1093/jat/14.3.149
  5. Z. Huang and S. Zhang, J. Chromatogr. B., 792(2), 241- 247(2003) https://doi.org/10.1016/S1570-0232(03)00269-1
  6. 대검찰청, "마약류범죄백서", 106-108, 2006
  7. C. E. Cook, A. R. Jeffcoat, J. M. Hill, D. E. Pugh, P. K. Patetta, B. M. Sadler, W. R. White, and M. Perez- Reyes, Drug Metab. Dispos., 21(4), 717-723(1993)
  8. H. H. Maurer, Ther. Drug Monit., 18(4), 465-470(1996) https://doi.org/10.1097/00007691-199608000-00027
  9. H. K. Ensslin, K. A. Kovar, and H. H. Maurer, J. Chromatogr. B., 683(2), 189-197(1996) https://doi.org/10.1016/0378-4347(96)00129-6
  10. M. Vaddevenne, H. Vandenbussche, and A. Verstraete, Acta Clin. Belgica, 55(6), 323-333(2000) https://doi.org/10.1080/17843286.2000.11754319
  11. M. R. Lee, S. C. Yu, C. L. Lin, and Y. C. Yeh, J. Anal. Toxicol., 21(4), 278-282(1997) https://doi.org/10.1093/jat/21.4.278
  12. B. K. Gan, D. Baugh, R. H. Liu, and A. S. Walia, J. Forensic. Sci., 36(5), 1331-1341(1991)
  13. C. Jurado, M. P. Gimenez, T. Soriano, M. Menendez, and M. Repetto, J. Anal. Toxicol., 24(1), 11-16(2000) https://doi.org/10.1093/jat/24.1.11
  14. P. R. Stout, C. K. Horn, and K. L. Klette, J. Anal. Toxicol., 26(5), 253-261(2002) https://doi.org/10.1093/jat/26.5.253
  15. K. L. Klette, M. H. Jamerson, C. L. Morris-Kukoski, A. R. Kettle, and J. J. Snyder, J. Anal. Toxicol., 29(7), 669-674(2005) https://doi.org/10.1093/jat/29.7.669
  16. K. L. Klette, A. R. Kettle, and M. H. Jamerson, J. Anal. Toxicol., 30(5), 319-322(2006) https://doi.org/10.1093/jat/30.5.319
  17. S. O. Pirnay, T. T. Abraham, and M. A. Huestis, Clin. Chem., 52(9), 1728-1734(2006). https://doi.org/10.1373/clinchem.2006.069054
  18. G. W. kunsman, B. Levine, J. J. Kuhlman, R. L. Jones, R. O. Hughes, C. I. Fujiyama, and M. L. Smith, J. Anal. Toxicol., 20(7), 517-521(1996) https://doi.org/10.1093/jat/20.7.517
  19. I. Kim, J. M. Oyler, E. T. Moolchan, E. J. Cone, and M. A. Huestis, Ther. Drug. Monit., 26(6), 664-672(2004) https://doi.org/10.1097/00007691-200412000-00013